ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 481 filers reported holding ISHARES TR in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,124,560 | -2.5% | 316,000 | 0.0% | 2.91% | +4.8% |
| Q4 2022 | $32,939,840 | +14.2% | 316,000 | 0.0% | 2.78% | +2.5% |
| Q3 2022 | $28,848,000 | -9.1% | 316,000 | 0.0% | 2.71% | +0.6% |
| Q2 2022 | $31,736,000 | -6.0% | 316,000 | 0.0% | 2.69% | +5.0% |
| Q1 2022 | $33,777,000 | +5.8% | 316,000 | 0.0% | 2.56% | +8.6% |
| Q4 2021 | $31,913,000 | +7.1% | 316,000 | 0.0% | 2.36% | +1.3% |
| Q3 2021 | $29,786,000 | -2.4% | 316,000 | 0.0% | 2.33% | -4.7% |
| Q2 2021 | $30,503,000 | +1.7% | 316,000 | 0.0% | 2.44% | -15.4% |
| Q1 2021 | $29,985,000 | +8.2% | 316,000 | 0.0% | 2.89% | +1.1% |
| Q4 2020 | $27,704,000 | +8.9% | 316,000 | 0.0% | 2.86% | +6.3% |
| Q3 2020 | $25,432,000 | -0.8% | 316,000 | 0.0% | 2.69% | -7.3% |
| Q2 2020 | $25,643,000 | +61.4% | 316,000 | +42.3% | 2.90% | +25.9% |
| Q1 2020 | $15,884,000 | -27.0% | 222,000 | 0.0% | 2.30% | -3.1% |
| Q4 2019 | $21,772,000 | +4.2% | 222,000 | 0.0% | 2.38% | -1.8% |
| Q3 2019 | $20,904,000 | -0.4% | 222,000 | 0.0% | 2.42% | -5.6% |
| Q2 2019 | $20,979,000 | +1.3% | 222,000 | 0.0% | 2.56% | -3.5% |
| Q1 2019 | $20,710,000 | +10.6% | 222,000 | 0.0% | 2.66% | +2.0% |
| Q4 2018 | $18,732,000 | -6.8% | 222,000 | 0.0% | 2.60% | +0.8% |
| Q3 2018 | $20,100,000 | +6.5% | 222,000 | 0.0% | 2.58% | -3.7% |
| Q2 2018 | $18,868,000 | +0.6% | 222,000 | 0.0% | 2.68% | -6.7% |
| Q1 2018 | $18,755,000 | -6.3% | 222,000 | 0.0% | 2.88% | -4.8% |
| Q4 2017 | $20,011,000 | +4.9% | 222,000 | 0.0% | 3.02% | +7.2% |
| Q3 2017 | $19,081,000 | +3.4% | 222,000 | 0.0% | 2.82% | +3.6% |
| Q2 2017 | $18,455,000 | +91.4% | 222,000 | +93.0% | 2.72% | +71.2% |
| Q1 2017 | $9,644,000 | +2.0% | 115,000 | 0.0% | 1.59% | -0.1% |
| Q4 2016 | $9,459,000 | -23.2% | 115,000 | -24.1% | 1.59% | -28.5% |
| Q3 2016 | $12,314,000 | +30.3% | 151,500 | +31.7% | 2.22% | +20.3% |
| Q2 2016 | $9,447,000 | +5.3% | 115,000 | 0.0% | 1.85% | -5.4% |
| Q1 2016 | $8,971,000 | +112.5% | 115,000 | +100.0% | 1.95% | +172.9% |
| Q4 2015 | $4,221,000 | – | 57,500 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVS HEALTH Corp | 624,536 | $62,722,000 | 52.01% |
| Angeles Investment Advisors, LLC | 2,162,920 | $217,222,000 | 19.86% |
| Bull Oak Capital, LLC | 162,500 | $16,320,000 | 15.09% |
| Essex Private Wealth Management, LLC | 38,182 | $3,835,000 | 14.33% |
| VAUGHAN & Co SECURITIES, INC. | 145,498 | $14,612,000 | 11.71% |
| SWISS RE LTD | 564,820 | $56,725,000 | 11.35% |
| Rain Capital Management, LLC | 133,852 | $13,443,000 | 9.66% |
| Titus Wealth Management | 189,826 | $19,064,000 | 9.55% |
| MCIA Inc | 182,506 | $18,400,000 | 9.20% |
| Prostatis Group LLC | 55,911 | $5,615,175 | 8.75% |